Assessment of Patent related barriers for Indian manufacturers

The TFORD-COVID19-India has commissioned M/s Gnanlex Hermeneutics Private Limited (Gnanlex) to carry out patent searches and provide their opinion on the patent landscape in India for the drug candidates considered by the TFORD-COVID19-India and also provide insights into the the freedom-to-operate status for Indian manufacturers. Thanks to Gnanlex for providing timely assistance. This section is edited by Dr Vidula Walimbe ( at Venture Center).

Reports from Gnanlex Hermeneutics Pvt Ltd (Released on 28 June 2020)